Associated Papers
Relationship between single-nucleotide polymorphisms and cancer immunotherapy efficacy and toxicity: a systematic review.
Specchia M et al.
Frontiers in Oncology, 2025
Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma.
Boutros A et al.
Archives of Dermatological Research, 2024
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors.
Boutros A et al.
Immuno-oncology Technology, 2023
Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
Fathi F et al.
International Journal of Immunogenetics, 2020
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.
Wagner M et al.
Frontiers in Immunology, 2020
Association of programmed death-1 gene polymorphisms with the risk of basal cell carcinoma.
Fathi F et al.
International Journal of Immunogenetics, 2019
Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females.
Abo El-Khair SM et al.
Lupus, 2019
Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort.
Soelberg K et al.
Multiple Sclerosis and Related Disorders, 2018
Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus.
Johansson M et al.
Arthritis and Rheumatism, 2005
Select a paper to view details